Equity Analysis

Company Profile

Score Board

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.5800097

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

15.92

36691.51

EPS(TTM)

Face Value()

Div & Yield %:

81.65

0.19

As on: Feb 25, 2025 05:01 AM

Particulars
Company Name	Glenmark Pharmaceuticals Ltd
Face Value	1
BSE Code	532296
Year End	202403
Full Year
Equity ( in Cr.)	28.22
B.V.	848.60
Sales in Cr.	7,891.12
NP in Cr.	1,425.03
NP Var%	-10.00
Div%	250.00
CPS	57.70
EPS	50.50
Traded Value( in Lakhs)	220.22
52 Week High	1,830.00
52 Week Low	884.00
Price BSE	1,300.00
Price NSE	1,301.00
Market Capital( in Cr.)	36,691.51
P/C Ratio	22.50
P/E Ratio	25.70
Price Vs.BV	1.53
Latest Quarter
Year End	202412
Sales in Cr.	2,208.84
NP in Cr.	413.80
NP Var %	8,390.00
Trailing Twelve Months
Year End	202412
Sales	9,177.74
OPM	-29.92
NP	2,303.95
NP Var%	118.94
EPS	81.65
PE	15.92